⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001952201

Bobilev Dmitri

Reports to the SEC for 1 company · BOSTON, MA

Transactions

6

Companies

1

Filings

3

CIK

0001952201

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−550K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−152K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−91K sh	—	—	0
2024-01-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+152K sh	—	—	151,700
2024-01-04	Fusion Pharmaceuticals Inc.Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+91K sh	—	—	91,000
2022-11-07	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+550K sh	—	—	550,000

Recent filings

3

Accepted (ET)
Jun 44
Bobilev Dmitri0000950170-24-068889
SEC(opens sec.gov)
Jan 54
Bobilev Dmitri0000950170-24-002293
SEC(opens sec.gov)
Nov 74
Bobilev Dmitri0001209191-22-056027
SEC(opens sec.gov)

Companies

1

Fusion Pharmaceuticals Inc.Chief Medical Officer

Address

C/O FUSION PHARMACEUTICALS INC. TWO INTERNATIONAL PLACE, SUITE 2310

BOSTON, MA, 02110